Quick Answer
Ovid Therapeutics Inc. reported Shares Outstanding of 130.18 million shares for fiscal year 2025.
Ovid Therapeutics Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 130.18M | +83.3% |
| 2024 | 71.01M | +0.4% |
| 2023 | 70.69M | +0.3% |
| 2022 | 70.47M | +0.1% |
| 2021 | 70.36M | +7.0% |
| 2020 | 65.74M | +20.2% |
| 2019 | 54.71M | +121.9% |
| 2018 | 24.65M | +0.2% |
| 2017 | 24.61M | +150.1% |
| 2016 | 9.84M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 71.15M | +0.2% | +0.1% |
| June 30, 2025 | 71.11M | +0.2% | +0.0% |
| March 31, 2025 | 71.11M | +0.5% | +0.1% |
| December 31, 2024 | 71.01M | +0.4% | +0.0% |
| September 30, 2024 | 71.01M | +0.5% | +0.1% |
| June 30, 2024 | 70.97M | +0.5% | +0.3% |
| March 31, 2024 | 70.78M | +0.4% | +0.1% |
| December 31, 2023 | 70.69M | +0.3% | +0.0% |
- Ovid Therapeutics Inc. showed an increase of +83.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2016–2025 period, Ovid Therapeutics Inc.’s shares outstanding has grown by 1223.2% (from 9.84 million shares to 130.18 million shares).
- The most recent figure is from Ovid Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: